- Reports /
- Pet Veterinary Diet Market
Pet Veterinary Diet Market
Pet Veterinary Diet Market Research Report – Segmented By Specialty Type (Urinary tract disease, Diabetes, Renal, Digestive Sensitivity, Oral Care, Other Specialty Types), By Pet Type (Dog, Cat, Birds, Other Pet Types) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.
Table of contents
- Executive Summary
- Market Overview
- Industry Analysis
- Market Analysis
- By Specialty Type
- By Pet Type
- North America
- Europe
- Asia-Pacific
- Middle-East & Africa
- Latin America
- Company Analysis
- Competitive Analysis
- Research Methodology
- Appendix
Executive Summary
Pet Veterinary Diet Market was valued at US $2.02 billion in 2021 and is projected to grow at 6.49% CAGR over the forecast period to reach US $2.95 billion by 2027. Pet Veterinary Diet Market represented US $0.24 billion opportunity over 2019-2021 and estimated to create US $0.93 billion opportunity in 2027 over 2021.
Pet Veterinary Diet from Consainsights analyses the Pet Veterinary Diet Market in the Life Sciences industry over the forecast period to 2027.
Pet Veterinary Diet research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Pet Veterinary Diet segmentation includes Specialty Type, Pet Type and Geography.
Based on the Specialty Type, the Pet Veterinary Diet analysis covers Urinary tract disease, Diabetes, Renal, Digestive Sensitivity, Oral Care, Other Specialty Types.
In Specialty Type segment, Renal segment has highest cagr growth of 5.74%.
Based on the Pet Type, the Pet Veterinary Diet analysis covers Dog, Cat, Birds, Other Pet Types.
In Pet Type segment, Dog segment has highest cagr growth of 5.74%.
Based on the region, the Pet Veterinary Diet analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include Mars Inc., Hill's Pet Nutrition Inc., Nestle SA, Nisshin Pet Food, WellPet LLC, Blue Buffalo Pet Products Inc., iVet Professional Formulas, Farmina Pet Foods, Forza10 USA, The Higgins Group Corp and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.
Market Overview
Definition & Scope
The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
Currency, Year & Forecast
The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
Specialty Type
Introduction
In 2021, Urinary tract disease segment has the highest revenue of US $0.77 billion and is expected to grow at CAGR of 5.74% by 2027 Renal segment has highest cagr growth of 5.74%.
Urinary tract disease
Urinary tract disease segment was valued at US $0.68 billion in 2019 and is projected to grow at 5.74% CAGR over the forecast period to reach US $1.13 billion by 2027. Urinary tract disease segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.35 billion opportunity in 2027 over 2021.
Diabetes
Diabetes segment was valued at US $0.43 billion in 2019 and is projected to grow at 5.74% CAGR over the forecast period to reach US $0.71 billion by 2027. Diabetes segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.22 billion opportunity in 2027 over 2021.
Renal
Renal segment was valued at US $0.29 billion in 2019 and is projected to grow at 5.74% CAGR over the forecast period to reach US $0.47 billion by 2027. Renal segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.15 billion opportunity in 2027 over 2021.
Digestive Sensitivity
Digestive Sensitivity segment was valued at US $0.20 billion in 2019 and is projected to grow at 5.74% CAGR over the forecast period to reach US $0.33 billion by 2027. Digestive Sensitivity segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.10 billion opportunity in 2027 over 2021.
Oral Care
Oral Care segment was valued at US $0.16 billion in 2019 and is projected to grow at 5.74% CAGR over the forecast period to reach US $0.26 billion by 2027. Oral Care segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.08 billion opportunity in 2027 over 2021.
Other Specialty Types
Other Specialty Types segment was valued at US $0.03 billion in 2019 and is projected to grow at 5.74% CAGR over the forecast period to reach US $0.06 billion by 2027. Other Specialty Types segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.02 billion opportunity in 2027 over 2021.
Pet Type
Introduction
In 2021, Dog segment has the highest revenue of US $1.19 billion and is expected to grow at CAGR of 5.74% by 2027 Dog segment has highest cagr growth of 5.74%.
Dog
Dog segment was valued at US $1.05 billion in 2019 and is projected to grow at 5.74% CAGR over the forecast period to reach US $1.74 billion by 2027. Dog segment represented US $0.14 billion opportunity over 2019-2021 and estimated to create US $0.55 billion opportunity in 2027 over 2021.
Cat
Cat segment was valued at US $0.49 billion in 2019 and is projected to grow at 5.74% CAGR over the forecast period to reach US $0.82 billion by 2027. Cat segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.26 billion opportunity in 2027 over 2021.
Birds
Birds segment was valued at US $0.22 billion in 2019 and is projected to grow at 5.74% CAGR over the forecast period to reach US $0.37 billion by 2027. Birds segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.12 billion opportunity in 2027 over 2021.
Other Pet Types
Other Pet Types segment was valued at US $0.01 billion in 2019 and is projected to grow at 5.74% CAGR over the forecast period to reach US $0.02 billion by 2027. Other Pet Types segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.01 billion opportunity in 2027 over 2021.